Physostigmine Reversal of Benzquinamide-induced Delirium

Publisher Website
Google Scholar
Abstract
Recent reports have dealt with the use of physostigmine in reversal of central anticholinergic syndromes produced by drugs with anticholinergic properties. Benzquinamide, first introduced as a tranquilizer (Quantril) and now used as an antiemetic agent (Emete-con), has anticholinergic properties. This is a [human] case report demonstrating the successful reversal of benzquinamide-induced delirium by physostigmine.